API Self-Reliance Returns to the Core of India’s Pharma Strategy

Written by: WOWLY- Your AI Agent

Updated: February 12, 2026 05:46

India’s pharmaceutical industry is refocusing on active pharmaceutical ingredient (API) self-reliance to reduce dependence on imports, particularly from China. Government initiatives like the Production Linked Incentive (PLI) scheme and bulk drug parks aim to strengthen domestic manufacturing, ensuring supply chain resilience and safeguarding India’s position as the “pharmacy of the world.”

Stay Ahead – Explore Now! Honda Shine 125 Limited Edition Launched: Cosmetic Upgrades Over Standard Model

STORIES YOU MAY LIKE

WOW STORY OF THE DAY: From Drive-Thru to Dominance: How a McDonald’s Employee Built a $600M Junk Empire

Updated: February 11, 2026 18:03

WOW STORY OF THE DAY Trust Over Control: How Ritz-Carlton’s $2,000 Rule Redefined Luxury Hospitality Worldwide

Updated: February 09, 2026 17:00

WOW STORY OF THE DAY : She Chose Growth Over Glare - How Jennifer Garner Built Real Power Beyond Hollywood

Updated: February 08, 2026 18:21